EUVIMEDEUVIMED entdecken
Vergleichsstudie

COMPARISON OF ADCC AND NK ACTIVITIES OF PERIPHERAL BLOOD MONONUCLEAR CELLS FROM PATIENTS AT RISK FOR ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)

J Wisecarver, T Bechtold, H Lipscomb, J Davis, M Collins, D Purtilo, J A Sonnabend

AIDS Research · 1983

DOI: 10.1089/aid.1.1983.1.347 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift AIDS Research, 1983. Verfasst von J Wisecarver und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Antibody-Dependent Cell Cytotoxicity. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: PHS HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibody-Dependent Cell CytotoxicityAcquired Immunodeficiency SyndromeAntibodies, MonoclonalHumansKiller Cells, NaturalLymphatic DiseasesLymphocytesMaleT-Lymphocytes, Helper-InducerT-Lymphocytes, Regulatory

Substanzen

Antibodies, Monoclonal

Förderung

  • PHS HHS

Zitieren

APA

Wisecarver, J., Bechtold, T., Lipscomb, H., Davis, J., Collins, M., Purtilo, D., & Sonnabend, J. A. (1983). COMPARISON OF ADCC AND NK ACTIVITIES OF PERIPHERAL BLOOD MONONUCLEAR CELLS FROM PATIENTS AT RISK FOR ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS). AIDS Research. https://doi.org/10.1089/aid.1.1983.1.347

Vancouver

Wisecarver J, Bechtold T, Lipscomb H, Davis J, Collins M, Purtilo D, et al. COMPARISON OF ADCC AND NK ACTIVITIES OF PERIPHERAL BLOOD MONONUCLEAR CELLS FROM PATIENTS AT RISK FOR ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS). AIDS Research. 1983. doi:10.1089/aid.1.1983.1.347

BibTeX
@article{Wisecarver1983,
  author = {Wisecarver, J and Bechtold, T and Lipscomb, H and Davis, J and Collins, M and Purtilo, D and Sonnabend, J A},
  title = {COMPARISON OF ADCC AND NK ACTIVITIES OF PERIPHERAL BLOOD MONONUCLEAR CELLS FROM PATIENTS AT RISK FOR ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)},
  journal = {AIDS Research},
  year = {1983},
  doi = {10.1089/aid.1.1983.1.347}
}
Kostenlos starten →